Published in Pediatr Res on May 01, 2002
Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure. Microb Ecol Health Dis (2012) 1.39
Intestinal fucose as a mediator of host-microbe symbiosis. J Immunol (2015) 0.81
Biogenic amine production by the wine Lactobacillus brevis IOEB 9809 in systems that partially mimic the gastrointestinal tract stress. BMC Microbiol (2012) 0.77
Local administration of 2% trimecaine affects the content of fucosylated glycoconjugates in goblet cells in rabbit tracheal epithelium. Int J Exp Pathol (2006) 0.75
Effects of fructooligosaccharides on cecum polyamine concentration and gut maturation in early-weaned piglets. J Clin Biochem Nutr (2011) 0.75
Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem (2002) 2.06
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology (2005) 1.24
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile. Neuropsychopharmacology (2006) 1.14
The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases. Biochem J (2003) 1.02
Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing. Int J Cancer (2002) 0.97
SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. J Pharmacol Exp Ther (2002) 0.95
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacol Biochem Behav (2008) 0.89
SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. CNS Drug Rev (2003) 0.89
SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties. J Pharmacol Exp Ther (2002) 0.88
In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multi-injection approach. J Cereb Blood Flow Metab (2009) 0.86
Regioselective cobalt-catalyzed formation of bicyclic 3- and 4-aminopyridines. Org Lett (2011) 0.86
Synthesis of aminopyridines and aminopyridones by cobalt-catalyzed [2+2+2] cycloadditions involving yne-ynamides: scope, limitations, and mechanistic insights. Chemistry (2012) 0.85
Regulation of the intestinal glycoprotein glycosylation during postnatal development: role of hormonal and nutritional factors. Biochimie (2003) 0.84
Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A. Bioorg Med Chem Lett (2003) 0.83
Mapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone. J Pharmacol Exp Ther (2003) 0.83
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile. Neuropsychopharmacology (2003) 0.81
Synthesis and biological evaluation of analogues of M6G. Eur J Med Chem (2011) 0.80
Glucocorticoid-induced maturation of glycoprotein galactosylation and fucosylation processes in the rat small intestine. J Steroid Biochem Mol Biol (2003) 0.80
Expression of galectin 4 in the rat small intestine during postnatal development. Biochimie (2004) 0.78
[(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse (2010) 0.78
Expression and localization of galectin 4 in rat stomach during postnatal development. Int J Biochem Cell Biol (2004) 0.77
Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors. Bioorg Med Chem (2004) 0.77
Interfacing chemical biology and drug discovery: report from the 50th International Conference on Medicinal Chemistry of the SCT (French Medicinal Chemistry Society), July 2-4, 2014, Rouen, France. ACS Chem Biol (2014) 0.75
Chemical biology: contribution to molecular therapeutic innovation--a new role for chemistry? Report from the thematic symposium organized by the SCT (French Medicinal Chemistry Society), November 26th, 2013. ACS Chem Biol (2014) 0.75
Solid-phase syntheses of 6-arylpyridazin-3(2H)-ones. J Comb Chem (2005) 0.75
Synthesis of new potentially bioactive bicyclic 2-pyridones. Molecules (2005) 0.75
Ring expansion of cyclic β-amino alcohols induced by diethylaminosulfur trifluoride: synthesis of cyclic amines with a tertiary fluorine at C3. J Org Chem (2012) 0.75